NASDAQ$HCAT
Health Catalyst Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Health Catalyst began the year by achieving strong performance across its business, including exceeding the mid-point of its quarterly guidance for both revenue and Adjusted EBITDA.
Health Catalyst reported strong first quarter results, exceeding revenue and Adjusted EBITDA guidance. The company achieved positive Adjusted EBITDA, fulfilling a commitment made at the time of its IPO.
- Total revenue for the quarter was $68.09 million, a 22% increase year-over-year.
- Technology revenue increased by 25% year-over-year to $42.23 million.
- Professional services revenue increased by 17% year-over-year to $25.86 million.
- Adjusted EBITDA was $671 thousand, compared to a loss of $837 thousand in the same quarter last year.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$68.1M
Revenue by segment
Health Catalyst · $68.1M total across 2 segments · Q1 2022
- Technology$42.2M+24.8%62.0%
- Professional Services$25.9M+17.5%38.0%
Forward guidance
For the second quarter of 2022, Health Catalyst expects total revenue between $68.0 million and $71.0 million, and Adjusted EBITDA between $(1.5) million and $0.5 million. For the full year of 2022, the company expects total revenue between $287.8 million and $292.8 million, and Adjusted EBITDA between $(4.0) million and $(2.0) million.
Tailwinds
- Total revenue between $68.0 million and $71.0 million for Q2 2022
- Adjusted EBITDA between $(1.5) million and $0.5 million for Q2 2022
- Total revenue between $287.8 million and $292.8 million for the full year 2022
- Adjusted EBITDA between $(4.0) million and $(2.0) million for the full year 2022
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2022
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro